|
Stay up-to-date with the latest O&T News in Europe
Read EFORT's official Newsletter with a round up of all EFORT activities
|
|
|
|
|
|
|
|
26th EFORT annual Congress
|
Last Call: Share Your Research Now!
|
|
|
Don’t miss your chance to contribute to the conversation on "Modern Technologies in Orthopaedics: Challenging Ethics and Outcomes" at the 26th EFORT annual Congress.
|
|
|
|
|
|
|
|
|
|
High-quality instructional peer-reviewed articles
across the whole field of Orthopaedics and Traumatology
|
|
|
|
|
|
|
Save the date for the upcoming EFORT Webinar
|
On Monday 25 November 2024 at 19:00 CET, the EFORT Webinar will focus on Management Options For Acute Prosthetic Joint Infections. This event will be chaired by José Cordero-Ampuero, Spain
The objectives of this webinar are:
- Specific points and "tricks" for common options in treatment of acute PJIs.
- Knowledge of provocative / innovative / unusual options in special situations.
- Clarification of ideas about how to individualise management of acute PJIs.
This Webinar was organised by EFORT independent of any commercial educational support.
|
|
|
|
|
|
|
|
Medical Device Regulations in Europe
|
Debate on accelerating the MDR evaluation:
BioMed Alliance Statement
|
EFORT is member of the Biomedical Alliance, representing 35 scientific societies at the European level. Through the Biomedical Alliance, EFORT is playing an active role on major health related issues, one of which is the Medical Device Regulation. This piece of legislation was designed to ensure the safety and effectiveness of medical devices through stringent standards. Still, its implementation is raising a number of serious concerns that impacts availability of devices at the EU level.
|
|
|
Following the recent plenary session of the European Parliament, the BioMed Alliance publishes a new statement sharing its concerns about the debate on accelerating the evaluation of the Medical Devices Regulation (MDR).
|
|
|
|
The Alliance agrees that immediate short-term measures are necessary to address pressing issues, including the limited availability of orphan and paediatric devices, however hastily revising the regulation without careful consideration of the impact and consultation with stakeholders risks compromising its robustness. Moreover, these changes may fail to address the deeper structural issues behind the delays, such as problems related to high costs of certification, innovation leaving the market and governance issues.
|
|
|
|
|
|
|
|
Industry O&T Product News
|
*This section provides news, offers and an overview of orthopaedic & traumatology-related products in form of paid advertisement plans. We believe the information to be accurate, timely and qualitatively high enough to interest the orthopaedic and traumatology community, however due to the fact that we rely on information provided by external sources we are not in a position to make any warranty or guarantee concerning the accuracy or reliability of the content at this site or other sites to which we link. Hence their scientific content is not necessarily endorsed by EFORT, unless stated otherwise.
|
|
|
|
|
|
|
A quick access to prime educational material
|
|
|
|
|
|
